Stock-Based Stock Options for Directors
First written in FY2017-Q1. 12 of 14 entries say "Advanced", first in FY2017-Q2. Latest entry: FY2025-Q1.
15 other companies' latest entry also says "Advanced".
- FY2025-Q1AdvancedAnnual report
「Class and number of shares to be disposed of: 18,000 common shares of the Company Recipients and their number, and number of shares to be disposed of: 3 directors of the Company, excluding outside directors, 18,000 shares」
The transition from the former stock-based compensation stock option plan to the restricted stock compensation plan took concrete form through the disposal of 18,000 treasury shares to 3 eligible directors. - FY2024ReframedAnnual report
「Based on a resolution at the 77th Annual General Meeting of Shareholders held on 23 May 2024, the Company introduced a restricted stock compensation plan. Accordingly, it abolished its former stock-based compensation stock option plan and has not issued any new stock acquisition rights, except for those already granted.」
Director stock-based compensation changed from the former stock option plan to a restricted stock compensation plan, and the policy became not to issue any new stock acquisition rights. - FY2023AdvancedAnnual report
「2017 stock options Exercise of rights 1,600 / 2018 stock options Exercise of rights 2,500 / 2019 stock options Exercise of rights 10,000」
During the fiscal year, a total of 14,100 shares were exercised under the reporting company's 2017, 2018 and 2019 stock options. - FY2022AdvancedAnnual report
「The reduction of 3,017,600 treasury common shares consisted of a 3,000,000-share reduction from the cancellation of treasury shares and a 17,600-share reduction from the exercise of stock options.」
The exercise of stock options, including those for directors, reduced treasury shares by 17,600 during the fiscal year. - FY2021AdvancedAnnual report
「Exercise of rights 7,500」
During the consolidated fiscal year, 7,500 shares were exercised under the 2019 stock options, leaving 27,500 shares unexercised. - FY2020-Q2AdvancedAnnual report
「Resolution date: 19 June 2019 Class and number of grantees (people): Directors of the Company 5 Number of stock acquisition rights (units)*: 350 Class, description and number of shares underlying the stock acquisition rights (shares)*: Common shares 35,000 Exercise period for stock acquisition rights*: 1 August 2019–31 July 2049」
The terms disclosed at the time of issuance on 31 July 2019 for 350 stock acquisition rights, representing 35,000 underlying shares, granted to 5 directors. - FY2020-Q1AdvancedAnnual report
「At a meeting of the Company's Board of Directors held on 19 June 2019, it was resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to issue stock acquisition rights to 5 of the Company's directors as stock-based compensation stock options.」
It was resolved to issue 350 stock acquisition rights for 5 directors, with an exercise period from 1 August 2019 to 31 July 2049. - FY2019AdvancedAnnual report
「The reduction of 23,400 treasury common shares resulted from the exercise of stock options.」
During the fiscal year, 23,400 shares were exercised under the stock option plan for directors, reducing treasury shares. - FY2019-Q2AdvancedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
260 stock acquisition rights, representing 26,000 underlying shares, were actually issued under the stock-based compensation stock option plan for directors. - FY2019-Q1AdvancedAnnual report
「At a meeting of the Company's Board of Directors held on 20 June 2018, it was resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to issue stock acquisition rights to 6 of the Company's directors as stock-based compensation stock options.」
It was resolved to issue 260 stock acquisition rights as stock-based compensation stock options to be allocated to 6 directors. - FY2018-Q2AdvancedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
215 stock acquisition rights, representing 21,500 underlying shares, were actually issued to directors. The exercise period runs from 1 August 2017 to 31 July 2047. - FY2018-Q1AdvancedAnnual report
「At a meeting of the Company's Board of Directors held on 7 July 2017, it was resolved, pursuant to Articles 236, 238 and 240 of the Companies Act, to issue stock acquisition rights to 7 of the Company's directors as stock-based compensation stock options.」
It was resolved to issue 215 stock acquisition rights for 7 directors. The exercise period was set from 1 August 2017 to 31 July 2047. - FY2017-Q2AdvancedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
265 stock acquisition rights, representing 26,500 underlying shares, were issued under the stock-based compensation stock option plan for directors. - FY2017-Q1First statedAnnual report
「The company resolved to issue stock acquisition rights as stock-based compensation stock options to 6 directors. Number of stock acquisition rights to be allocated: 265. Each stock acquisition right represents 100 shares of the company's common stock. Exercise period: 1 August 2016 to 31 July 2046.」
The company reports a stock-based compensation program allocating 265 stock acquisition rights to 6 directors.